相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Effects of Serelaxin in Patients with Acute Heart Failure
Marco Metra et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Efficacy and safety of serelaxin when added to standard of care in patients with acute heart failure: results from a PROBE study, RELAX-AHF-EU
Aldo P. Maggioni et al.
EUROPEAN JOURNAL OF HEART FAILURE (2019)
The Efficacy, Safety, and Tolerability of Additional Serelaxin Administration to Standard Therapy in Asian Patients with Acute Heart Failure: The RELAX-AHF-ASIA trial
Naoki Sato et al.
JOURNAL OF CARDIAC FAILURE (2018)
RELAX-AHF, BLAST-AHF, TRUE-AHF, and other important truths in acute heart failure research
Gad Cotter et al.
EUROPEAN JOURNAL OF HEART FAILURE (2017)
Evaluating the Efficacy, Safety, and Tolerability of Serelaxin When Added to Standard Therapy in Asian Patients With Acute Heart Failure: Design and Rationale of RELAX-AHF-ASIA Trial
Naoki Sato et al.
JOURNAL OF CARDIAC FAILURE (2017)
Effects of serelaxin in acute heart failure patients with renal impairment: results from RELAX-AHF
Licette C. Y. Liu et al.
CLINICAL RESEARCH IN CARDIOLOGY (2016)
RELAX-REPEAT: A Multicenter, Prospective, Randomized, Double-Blind Study Evaluating the Safety and Tolerability of Repeat Doses of Serelaxin in Patients with Chronic Heart Failure
John R. Teerlink et al.
JOURNAL OF CARDIAC FAILURE (2016)
Pharmacokinetics of serelaxin in patients with hepatic impairment: a single-dose, open-label, parallel group study
Zhanna Kobalava et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Multicenter, Randomized, Double-Blinded, Placebo-Controlled Phase II Study of Serelaxin in Japanese Patients With Acute Heart Failure
Naoki Sato et al.
CIRCULATION JOURNAL (2015)
Safety and Tolerability of Serelaxin, a Recombinant Human Relaxin-2 in Development for the Treatment of Acute Heart Failure, in Healthy Japanese Volunteers and a Comparison of Pharmacokinetics and Pharmacodynamics in Healthy Japanese and Caucasian Populations
Marion Dahlke et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2015)
Renal Hemodynamic Effects of Serelaxin in Patients With Chronic Heart Failure A Randomized, Placebo-Controlled Study
Adriaan A. Voors et al.
CIRCULATION-HEART FAILURE (2014)
A randomized, double-blind, placebo-controlled, multicentre study to assess haemodynamic effects of serelaxin in patients with acute heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2014)
Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program Correlation With Outcomes
Marco Metra et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2013)
Serelaxin, recombinant human relaxin-2, for treatment of acute heart failure (RELAX-AHF): a randomised, placebo-controlled trial
John R. Teerlink et al.
LANCET (2013)
Diuretic Strategies in Patients with Acute Decompensated Heart Failure
G. Michael Felker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Conducting Meta-Analyses in R with the metafor Package
Wolfgang Viechtbauer
JOURNAL OF STATISTICAL SOFTWARE (2010)
First Clinical Experience with Intravenous Recombinant Human Relaxin in Compensated Heart Failure
Thomas Dschietzig et al.
RELAXIN AND RELATED PEPTIDES: FIFTH INTERNATIONAL CONFERENCE (2009)
Intravenous Recombinant Human Relaxin in Compensated Heart Failure: A Safety, Tolerability, and Pharmacodynamic Trial
Thomas Dschietzig et al.
JOURNAL OF CARDIAC FAILURE (2009)
Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study
John R. Teerlink et al.
LANCET (2009)
Practical methods for incorporating summary time-to-event data into meta-analysis
Jayne F. Tierney et al.
TRIALS (2007)
Short-term clinical effects of tolvaptan, an oral vasopressin antagonist, in patients hospitalized for heart failure - The EVEREST clinical status trials
Mihai Gheorghiade et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
分享论文
